Literature DB >> 16232210

The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.

C S Barrios1, B D Johnson, J D Henderson, J N Fink, K J Kelly, V P Kurup.   

Abstract

Aspergillus fumigatus (Af) is a fungus associated with allergic bronchopulmonary aspergillosis (ABPA) and other allergic diseases. Immune responses in these diseases are due to T and B cell responses. T cell activation requires both Af-specific engagement of the T-cell-receptor as well as interaction of antigen independent costimulatory molecules including CD28-CD80/CD86 and OX40-OX40L interactions. Since these molecules and their interactions have been suggested to have a potential involvement in the pathogenesis of ABPA, we have investigated their role in a model of experimental allergic aspergillosis. BALB/c mice were primed and sensitized with Af allergens, with or without exogenous IL-4. Results showed up-regulation of both CD86 and CD80 molecules on lung B cells from Af-sensitized mice (79% CD86+ and 24% CD80+) and Af/rIL-4-treated mice (90% CD86+ and 24% CD80+) compared to normal controls (36% and 17%, respectively). Lung macrophages in Af-sensitized mice treated or not with IL-4 showed enhanced expression of these molecules. OX40L expression was also up-regulated on lung B cells and macrophages from both Af-sensitized and Af/rIL-4 exposed mice as compared to normal controls. All Af-sensitized animals showed peripheral blood eosinophilia, enhanced total serum IgE and allergen-specific IgG1 antibodies and characteristic lung inflammation. The up-regulation of CD80, CD86 and OX40L molecules on lung B cells and macrophages from Af-allergen exposed mice suggests a major role for these molecules in the amplification and persistence of immunological and inflammatory responses in ABPA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232210      PMCID: PMC1809515          DOI: 10.1111/j.1365-2249.2005.02905.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice.

Authors:  A Haczku; K Takeda; I Redai; E Hamelmann; G Cieslewicz; A Joetham; J Loader; J J Lee; C Irvin; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  Determinants of infant responses to vaccines in presence of maternal antibodies.

Authors:  C A Siegrist; M Córdova; C Brandt; C Barrios; M Berney; C Tougne; J Kovarik; P H Lambert
Journal:  Vaccine       Date:  1998 Aug-Sep       Impact factor: 3.641

4.  CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells.

Authors:  P Jeannin; Y Delneste; S Lecoanet-Henchoz; J F Gauchat; J Ellis; J Y Bonnefoy
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

5.  Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis.

Authors:  O Jirapongsananuruk; M F Hofer; A E Trumble; D A Norris; D Y Leung
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

6.  Immune responses to Aspergillus antigen in IL-4-/-mice and the effect of eosinophil ablation.

Authors:  V P Kurup; H Y Choi; P S Murali; J Q Xia; R L Coffman; J N Fink
Journal:  Allergy       Date:  1999-05       Impact factor: 13.146

7.  Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis.

Authors:  M Skov; L K Poulsen; C Koch
Journal:  Pediatr Pulmonol       Date:  1999-02

8.  Aspergillus fumigatus antigen exposure results in pulmonary airway resistance in wild-type but not in IL-4 knockout mice.

Authors:  V P Kurup; J Q Xia; D A Rickaby; C A Dawson; H Choi; J N Fink
Journal:  Clin Immunol       Date:  1999-03       Impact factor: 3.969

Review 9.  T cell activation, from atopy to asthma: more a paradox than a paradigm.

Authors:  M El Biaze; S Boniface; V Koscher; E Mamessier; P Dupuy; F Milhe; M Ramadour; D Vervloet; A Magnan
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

10.  Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis.

Authors:  B Banerjee; P A Greenberger; J N Fink; V P Kurup
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  10 in total

1.  Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.

Authors:  Lee B Rivera; David Meyronet; Valérie Hervieu; Mitchell J Frederick; Emily Bergsland; Gabriele Bergers
Journal:  Cell Rep       Date:  2015-04-16       Impact factor: 9.423

2.  Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.

Authors:  Peyman Rajabi; Mahsa Alaee; Kazem Mousavizadeh; Ali Samadikuchaksaraei
Journal:  Inflamm Res       Date:  2012-07-31       Impact factor: 4.575

3.  Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.

Authors:  Wei Duan; Takanori So; Michael Croft
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

4.  Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses.

Authors:  K Kulhankova; C L S George; J N Kline; J M Snyder; M Darling; E H Field; P S Thorne
Journal:  Clin Exp Allergy       Date:  2009-04-28       Impact factor: 5.018

5.  Immune response modulation by curcumin in a latex allergy model.

Authors:  Viswanath P Kurup; Christy S Barrios; Raghavan Raju; Bryon D Johnson; Michael B Levy; Jordan N Fink
Journal:  Clin Mol Allergy       Date:  2007-01-25

6.  Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium.

Authors:  Jose Manuel Sánchez-Maldonado; Ana Moñiz-Díez; Rob Ter Horst; Daniele Campa; Antonio José Cabrera-Serrano; Manuel Martínez-Bueno; María Del Pilar Garrido-Collado; Francisca Hernández-Mohedo; Laura Fernández-Puerta; Miguel Ángel López-Nevot; Cristina Cunha; Pedro Antonio González-Sierra; Jan Springer; Michaela Lackner; Laura Alcazar-Fuoli; Luana Fianchi; José María Aguado; Livio Pagano; Elisa López-Fernández; Esther Clavero; Leonardo Potenza; Mario Luppi; Lucia Moratalla; Carlos Solano; Antonio Sampedro; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; Federico Canzian; Juergen Loeffler; Yang Li; Hermann Einsele; Mihai G Netea; Lourdes Vázquez; Agostinho Carvalho; Manuel Jurado; Juan Sainz
Journal:  J Fungi (Basel)       Date:  2020-12-23

7.  Immune response among patients exposed to molds.

Authors:  David A Edmondson; Christy S Barrios; Trevor L Brasel; David C Straus; Viswanath P Kurup; Jordan N Fink
Journal:  Int J Mol Sci       Date:  2009-12-21       Impact factor: 5.923

8.  TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.

Authors:  Nidhi Jain; Bhavya Khullar; Neelam Oswal; Balaji Banoth; Prashant Joshi; Balachandran Ravindran; Subrat Panda; Soumen Basak; Anna George; Satyajit Rath; Vineeta Bal; Shailaja Sopory
Journal:  Dis Model Mech       Date:  2016-04-28       Impact factor: 5.758

Review 9.  The Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus.

Authors:  Intan M W Dewi; Frank L van de Veerdonk; Mark S Gresnigt
Journal:  J Fungi (Basel)       Date:  2017-10-04

Review 10.  Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface.

Authors:  Won-Ha Lee; Donggun Seo; Su-Geun Lim; Kyoungho Suk
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.